NYSE : ALX
-$10.27 (-3.59%)
NYSE
Steven Roth
REIT - Retail
Real Estate
ALX
103
US
USD
10.42
8.36
8.36
2.00
4.49
$213.18M
6.66
15.62
21.83
12.57
$5.5
$28.22M
9.72%
9.72%
17.37%
1.88%
68.96
-1.43
-1.43
$212.00
$212.00
$212.00
2/5
2 Analysts
30.11%
1.64
6/9
$279.77M
$1.1B
$1.01B
$72.13M
$2.32B
10.95
21.27
8.36
17.37%
5.67%
1.41%
4.46%
$39.90
12 days
| Name | Title |
|---|---|
| Steven J. Borenstein | Secretary |
| Gary W. Hansen | Chief Financial Officer |
| Steven Roth | Chairman of the Board & Chief Executive Officer |
No votes yet today — be the first to share your view!
About Alexander's, Inc. (NYSE:ALX) Stock
Alexander's, Inc., a real estate investment trust, possesses a portfolio comprising seven properties located across the broader New York City metropolitan region. ...
2026-07-21 12:23:00
PARAMUS, N.J., July 21, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended June 30, 2026 with the U.S. Securities and Exchange Commission and issue its second quarter earnings release on Monday, August 3, 2026, before the New York Stock Exchange opens.
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
2026-06-30 16:40:00
SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced that the Compensation Committee of the Board of Directors of ALX Oncology approved the granting of an inducement stock option to purchase a total of 500,000 shares of ALX Oncology's common stock to Michael Listgarten, General Counsel, on June 29, 2026 in connection with the commencement of his employment. Mr. Listgarten's inducement stock option is subject to the terms of the ALX Oncology Holdings Inc. 2025 Inducement Equity Incentive Plan and related forms of agreements, and was granted as an inducement material to Mr. Listgarten to enter into employment with ALX Oncology in accordance with Nasdaq Listing Rule 5635(c)(4).
2026-06-30 08:00:00
Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Succeeds Co-Founder Corey Goodman, Ph.D., After More Than a Decade of Foundational Leadership SOUTH SAN FRANCISCO, Calif.
2026-06-29 17:22:19
PARAMUS, N. J. , June 29, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today that it has completed a 15-year lease (with renewal options) with Target Corporation at its Rego Park Shopping Center located on Junction Blvd at the Long Island Expressway, in the middle of densely populated Queens, New York.
2026-06-29 17:22:00
PARAMUS, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today that it has completed a 15-year lease (with renewal options) with Target Corporation at its Rego Park Shopping Center located on Junction Blvd at the Long Island Expressway, in the middle of densely populated Queens, New York.
2026-06-16 08:00:00
VANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | OTC: GXPLF | FRA: HW3), is pleased to announce that the Company has fulfilled all the obligations of its property option agreement (the “Agreement”) to earn a 100% legal and beneficial interest in the Carpenter Lake Uranium Project (“Carpenter Lake” or the “Project”), located on the southern margin of the Athabasca Basin in northern Saskatchewan, Canada. Greenridge entered into the Agreement in May 2024 with ALX Resources Corp. (“ALX”) and Renegade Gold Inc. (“Renegade” and together with ALX, the “Optionors”) and has since carried out systematic exploration at the Project, including diamond drilling, in 2024, 2025 and 2026.
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
2026-06-01 08:00:00
SOUTH SAN FRANCISCO, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in a fireside chat presentation at the 2026 Jefferies Global Healthcare Conference in New York.
Alexander’s Completes Sale of Rego Park I
2026-05-28 16:54:39
PARAMUS, N. J. , May 28, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today that it has completed the previously announced sale of its Rego Park I property, located in Queens, New York, to Northwell Health, Inc. The gross sales price was $235.
Frequently Asked Questions
What is the current Alexander's, Inc. (ALX) stock price?
Alexander's, Inc.(NYSE:ALX) stock price is $275.835 in the last trading session. During the trading session, ALX stock reached the peak price of $289.43 while $201.28 was the lowest point it dropped to. The percentage change in ALX stock occurred in the recent session was --3.59% while the dollar amount for the price change in ALX stock was -$10.27.
ALX's industry and sector of operation?
The NYSE listed ALX is part of REIT - Retail industry that operates in the broader Real Estate sector.
Who are the executives of ALX?
Steven J. Borenstein
| Secretary
Gary W. Hansen
| Chief Financial Officer
Steven Roth
| Chairman of the Board & Chief Executive Officer
|
|
How many employees does ALX have?
Number of ALX employees currently stands at 103. ALX operates from 210 Route 4 East, Paramus, NJ 07652, US.
Link for ALX official website?
Official Website of ALX is: https://www.alx-inc.com
How do I contact ALX?
ALX could be contacted at phone #201-587-8541 and can also be accessed through its website. ALX operates from 210 Route 4 East, Paramus, NJ 07652, US.
How many shares of ALX are traded daily?
The average number of ALX shares traded daily for last 3 months was 37.98K.
What is the market cap of ALX currently?
The market value of ALX currently stands at $1.41B with its latest stock price at $275.835